Study on the rat pulmonary irritation of aerosol inhaled Tanreqing and Reduning
-
摘要: 目的 研究中药复方痰热清和单成分喜炎平注射液的雾化吸入对大鼠肺部的刺激性。 方法 每种药物分为高、低浓度2个实验组,对照组灌以生理盐水。雾化吸入药物给药7 d后处死大鼠。采用大鼠支气管肺泡灌洗术,测定灌洗液中总蛋白含量和LDH酶活性,以判断两种药物对大鼠肺部的损伤程度。 结果 痰热清低、高浓度组肺泡灌洗液中蛋白质浓度分别为:(193.78±27.74)、(235.33±50.41) μg/ml;喜炎平两组蛋白质浓度为:(174.02±17.82)、(227.27±66.03) μg/ml;LDH酶活力单位依次为:1065.21±181.76、1467.33±101.87;307.97±47.56、1377.29±566.48。经t检验,与对照组相比,痰热清和喜炎平(低浓度和高浓度)对肺泡灌洗液中总蛋白含量无显著影响,但均能增加LDH酶的活力(P<0.05),且与浓度呈正相关;低浓度痰热清组的LDH酶活力显著高于低浓度喜炎平组(P<0.05)。 结论 雾化吸入痰热清、喜炎平对大鼠呼吸系统有一定的刺激性,故不宜采用雾化吸入的给药方式。Abstract: Objective To study the rat pulmonary irritant of aerosol inhaled Tanreqing and Reduning injection. Methods Rats were devided into two groups for each medicine (low concentration group and high concentration group), nebulized drug administration for seven days, with the control group irrigated with saline, and were sacrificed. Through bronchoalveolar lavage, excurrent bronchoalveolar lavage fluid (BALF) was used for total protein determination and LDH vitality test to evaluate pulmonary toxicity of two medicines. Results The protein concentrations of two groups in low and high concentrations of Tanreqing and Reduning respectively are (193.78±27.74),(235.33±50.41) μg/ml;(174.02±17.82),(227.27±66.03) μg/ml;LDH vitalities respectively are 1065.21±181.76,1467.33±101.87;307.97±47.56,1377.29±566.48. By t-test, compared with normal saline, there was no significant effect among these five groups on protein concentration, but these two medicine were able to improve LDH activity (P<0.05) which was more obvious in high concentration group. When two medicines were in low concentration, LDH activity was higher in Tanreqing group with statistical significance (P<0.05). Conclusion Aerosol inhaled Tanreqing and Reduning injection in rats have some pulmonary irritation and potential safety hazard in this delivery way.
-
Key words:
- pulmonary delivery /
- Tanreqing /
- Reduning /
- excurrent bronchoalveolar lavage /
- irritation
-
[1] 凌 祥,沈 雁,孙春萌,等.肺部给药研究近况[J].药学研究,2014,33(12):711-714. [2] 王 淳,刘晓彬,权丽辉,等.中药肺部给药系统应用进展[J].世界科学技术:中医药现代化,2007,9(1):59-64. [3] 雷卫平,吴英梅,林翠芬.痰热清注射液的临床应用[J].国际医药卫生导报,2005,11(14):110-113. [4] 张 妍,杨毅恒,刘 芳,等.痰热清注射液雾化吸入治疗呼吸系统疾病的系统评价[J].中国医院用药评价与分析,2010,10(6):483-487. [5] 唐 韵.喜炎平注射液临床应用近况[J].世界临床药物,2014,35(3):184-188. [6] 万 珍,徐志锋,林俊明,等.喜炎平超声雾化吸入治疗成人急性上呼吸道感染疗效观察[J].新中医,2014,46(6):57-59. [7] 张华静,郑德瑜.喜炎平注射液联合利巴韦林雾化吸入治疗小儿疱疹性咽峡炎观察[J].中医药临床杂志,2014,26(12):1247-1248. [8] 王 晶,任吉祥,谢雁鸣,等.喜炎平注射液治疗手足口病的系统评价[J].中国中药杂志,2013,38(18):3215-3222. [9] 耿 红,吴明杰.喜炎平雾化吸入后拍背吸痰佐治小儿毛细支气管炎的临床观察[J].临床合理用药杂志,2012,5(6B):70
计量
- 文章访问数: 2814
- HTML全文浏览量: 308
- PDF下载量: 598
- 被引次数: 0